Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori

BACKGROUND: Helicobacter pylori (HP) infection is associated with reduced lung function and systemic inflammation in chronic obstructive pulmonary disease (COPD) patients. Azithromycin (AZ) is active against HP and reduces the risk of COPD exacerbation. We determined whether HP infection status modi...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Respir Res
Main Authors: Ra, Seung Won, Sze, Marc A., Lee, Eun Chong, Tam, Sheena, Oh, Yeni, Fishbane, Nick, Criner, Gerard J., Woodruff, Prescott G., Lazarus, Stephen C., Albert, Richard, Connett, John E., Han, Meilan K., Martinez, Fernando J., Aaron, Shawn D., Reed, Robert M., Man, S. F. Paul, Sin, Don D.
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2017
Fag:
Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5450077/
https://ncbi.nlm.nih.gov/pubmed/28558695
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-017-0594-x
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker